Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.

Antimicrobial Agents and Chemotherapy
L W AyersH M Sommers

Abstract

Cefotetan is a new, potent, 7 alpha-methoxy cephalosporin (cephamycin). The in vitro activity of cefotetan tested in a multiphasic, collaborative study against 12,260 consecutive clinical isolates and 448 selected isolates showed 93% of Enterobacteriaceae, 90% of methicillin-susceptible Staphylococcus aureus (broth dilution), 83% of Bacteroides fragilis, and 72% of non-enterococcal streptococci to be inhibited by less than or equal to 8 micrograms/ml. Beta-Lactamase-producing and -nonproducing Haemophilus influenzae strains were inhibited by less than or equal to 1.0 micrograms/ml. Cefotetan's inhibitory spectrum paralleled those of the newest generation of cephems and exceeded those of cefoxitin and cefamandole. No useful activity was present against Streptococcus faecalis or Pseudomonas aeruginosa. Cefotetan was bactericidal without significant inoculum effect and was highly resistant to hydrolysis by Richmond-Sykes types I, III, and IV beta-lactamases. Hydrolysis of the chromogenic cephalosporin PADAC (pyridine-2-azo-p-dimethylaniline cephalosporin) by type I beta-lactamases was markedly inhibited by concentrations of cefotetan similar to those of the potent inhibitor dicloxacillin. Analysis of agar disk diffusion for severa...Continue Reading

References

Jun 1, 1976·The Journal of Antimicrobial Chemotherapy·R B Sykes, M Matthew
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Dec 1, 1974·The Journal of Infectious Diseases·C M Metzler, R M DeHaan
Dec 1, 1972·Antimicrobial Agents and Chemotherapy·C O'Callaghan, A Morris
May 1, 1980·Antimicrobial Agents and Chemotherapy·J H JorgensenG A Alexander
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·R N JonesH W Wilson
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·R N JonesE H Gerlach
Nov 1, 1980·Antimicrobial Agents and Chemotherapy·A L BarryE H Gerlach
Jan 1, 1981·The Journal of Antibiotics·M TodaS Mitsuhashi
Sep 1, 1981·The Journal of Antimicrobial Chemotherapy·V O Rotimi, D C Turk

❮ Previous
Next ❯

Citations

Jan 1, 1984·Diagnostic Microbiology and Infectious Disease·P C FuchsC Thornsberry
Sep 1, 1984·Diagnostic Microbiology and Infectious Disease·A L BarryR N Jones
Feb 1, 1988·Diagnostic Microbiology and Infectious Disease·C E EdmistonR E Condon
May 31, 1988·American Journal of Surgery·R N Jones
Jun 1, 1983·Antimicrobial Agents and Chemotherapy·M KonoT Hayasaka
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·L DubreuilC Romond
Sep 1, 1984·Antimicrobial Agents and Chemotherapy·M FuksaA Lee
May 1, 1986·Antimicrobial Agents and Chemotherapy·B R SmithJ J Zimmerman
Apr 1, 1986·American Journal of Obstetrics and Gynecology·J A McGregorE Makowski
Jun 7, 1985·The American Journal of Medicine·R N Jones
Nov 1, 1985·Drug Intelligence & Clinical Pharmacy·L A Farchione
Aug 1, 1987·Journal of Clinical Microbiology·A L Barry, R N Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

© 2021 Meta ULC. All rights reserved